Loading ABUS...
Arbutus Biopharma Corp.ABUSAs of 31 July 2026
−31
PositiveNegative
Equilibrium
Emotion
Is Arbutus Biopharma Corp. oversold, or is the crowd euphoric?
A read on the market's emotion around Arbutus Biopharma Corp. (ABUS): where sentiment sits between capitulation and euphoria, measured against the stock's own history so heavily covered and quieter names read on the same scale. Information, not advice.
Arbutus Biopharma Corp.ABUSLast 5 years
V—E—F—A—
——
ABUS priceasymmetryquant.com